Table 4.

Abnormal clinical findings at the start of the study and after 24 weeks of treatment.

	Treatment (N = 37)		Placebo (N = 39)		P value
	Week 0	Week 24	Week 0	Week 24	Weeks 0 and 24
SBP ≥ 140 or DBP ≥ 90 mmHg*	13 (35.1)	13 (33.3)	12 (32.4)	13 (33.3)	0.764, 0.933
Fasting glucose ≥ 126 mg/dL*	6 (16.2)	8 (21.6)	5 (12.8)	10 (25.6)	0.674, 0.680
AST or ALT ≥ 1.5 × upper limit of normal**	0 (0.0)	1 (2.7)	0 (0.0)	2 (5.1)	NA, 0.520
Creatinine ≥ 1.5 mg/dL**	0 (0.0)	1 (2.7)	0 (0.0)	0 (0.0)	NA, 0.487

AST: aspartate transaminase; ALT: alanine transaminase; DBP: diastolic blood pressure; SBP: systolic blood pressure.

Data are expressed as frequency (percent). *Chi-square test or **Fisher's exact test.